Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicityUlrike Garske‐Román, Donald Granberg, Mattias Sandström et al.|European Journal of Nuclear Medicine and Molecular Imaging|2018Cited by 249
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATEAchyut Ram Vyakaranam, Anders Sundin, Ulrike Garske‐Román et al.|Cancers|2019Cited by 81